Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Patent
1996-03-28
1999-08-10
Eisenschenk, Frank C.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
424450, 424451, 424490, 4241391, 4241981, 4241301, 514 2, A61K 700, A61K 748, A61K 3900, A61K 39395
Patent
active
059355867
ABSTRACT:
Lichens, prurigos, pruriginous toxidermias and/or severe pruritus afflicting a mammalian, notably human patient, are therapeutically treated by administrating to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist.
REFERENCES:
patent: 5445823 (1995-08-01), Hall et al.
Lundbad et al. 1987 Allergy 42 (1) pp. 20-25, Jan. 1987.
Vaalasti et al. 1989 Br. J Dermatology 120 (5) pp. 619-623, May 1989.
Neuroscience, vol. 48, No. 4, Jun. 1992, pp. 963-968, T.L. Buckley, et al., `The Partial Inhibition of Inflammatory Responses Induced by a Capsaicin Using the Fab Fragment of a Selective Calcitonin Gene-Related Peptide Antiserum in Rabbit Skin.`
British Journal of Pharmacology, vol. 110, No. 2, 1993, pp. 772-776, K. Jane Escott, et al., `Effect of Calcitonin Gene-Related Peptide Antagonist (CGRP 8-37) on Skin Vasodilatation and Oedema Induced by Stimulation of the Rat Saphenous Nerve.`
British Journal of Pharmacology, vol. 104, No. 3, Nov. 1991, pp. 738-742, S.R. Hughes, et al., `A Calcitonin Gene-Related Peptide (CGRP) Antagonist (CGRP 8-37) Inhibits Microvascular Responses Induced by CGRP and Capsaicin in Skin.`
Neuroscience Letters, vol. 102, No. 2.3, Jul. 31, 1989, pp. 257-260, S.M. Louis, et al., `Antibodies to Calcitonin Gene-Related Peptide Reduce Inflammation Induced by Topical Mustard Oil But Not That Due To Carrageenin in the Rat.`
Hua et al. 1993 J Neurosci 13 (5) pp. 1947-1953, May 1, 1993.
Ostlere et al. 1995 Clinical and Experimental Dermatology 20 (nov) pp. 462-467, Nov. 1, 1995.
Peskar et al. 1993 Eur J Pharmacology 250 pp. 201-203, Jan. 1, 1993.
Shaw et al. 1992 Br J Pharmacol 106 pp. 196-198, Jan. 1, 1992.
Bartho et al. 1991 Neuroscience Letters 129 pp. 156-159, Jan. 1, 1991.
Brain et al 1986 J Invest Dermatol 87 pp. 533-536, Jan. 1, 1986.
Fuller et al. 1987 Br J Pharmacol 92 pp. 781-788, Jan. 1, 1987.
Herbert et al. 1994 Br J Pharmacol 111 pp. 681-686, Jan. 1, 1994.
Tan et al. 1995 Clinical Science 89 pp. 565-5733, Dec. 1, 1995.
Wallengren et al. 1987 Eur J Pharmacol 143 pp. 267-273, Nov. 10, 1987.
Breton Lionel
De Lacharriere Olivier
Eisenschenk Frank C.
Societe l'Oreal S.A.
Zeman Mary K
LandOfFree
Therapeutic/cosmetic compositions comprising CGRP antagonists fo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic/cosmetic compositions comprising CGRP antagonists fo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic/cosmetic compositions comprising CGRP antagonists fo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117650